Dechra Pharmaceuticals plc (DPH.L)
Dechra Pharmaceuticals plc develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals plc was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.
Company Info
| ISIN | GB0009633180 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Highlights
| Market Cap | £4.40B |
|---|---|
| EPS (TTM) | -£0.25 |
| Year Range | £3,680.00 - £3,868.00 |
| Target Price | £4,189.00 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: DPH.L vs. AZN.L
Performance
Performance Chart
The chart shows the growth of an initial investment of £10,000 in Dechra Pharmaceuticals plc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | N/A | 13.39% |
| 1 month | N/A | 4.02% |
| 6 months | N/A | 5.56% |
| 1 year | N/A | 21.51% |
| 5 years (annualized) | N/A | 12.69% |
| 10 years (annualized) | N/A | 10.55% |
Monthly Returns
The table below presents the monthly returns of DPH.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 9.47% | -4.61% | -2.63% | 40.75% | -10.46% | 10.36% | 0.76% | 2.48% | -0.47% | 0.53% | 0.42% | 0.89% | 48.04% |
| 2022 | -21.99% | -0.87% | -1.22% | -10.31% | -0.05% | -4.90% | 6.54% | -5.27% | -24.87% | 1.15% | 3.82% | -3.75% | -50.09% |
| 2021 | 4.52% | -4.88% | 0.33% | 17.61% | 1.98% | 6.22% | 13.73% | 5.43% | -7.44% | 6.17% | -1.46% | 5.55% | 55.75% |
| 2020 | -1.93% | -6.96% | -10.78% | 17.77% | 0.43% | 2.30% | 0.35% | 10.29% | 2.35% | 8.31% | -2.96% | 2.50% | 20.21% |
| 2019 | 14.30% | 4.48% | 9.57% | -1.41% | 2.56% | 0.66% | 7.28% | 1.83% | -7.73% | -4.16% | 7.76% | 2.33% | 41.87% |
| 2018 | 14.50% | 4.92% | 4.67% | 4.34% | 1.82% | -0.36% | 7.33% | 4.49% | -30.19% | 5.83% | -5.51% | -4.17% | -0.13% |
| 2017 | 8.25% | 10.58% | 4.36% | 0.96% | 15.03% | -12.55% | 4.41% | 7.77% | 6.64% | 1.54% | 7.30% | -4.99% | 57.59% |
| 2016 | -8.69% | 14.63% | 5.93% | -8.29% | 6.42% | -0.42% | 13.48% | -2.26% | 7.15% | -2.51% | -5.28% | 5.57% | 24.85% |
| 2015 | 3.41% | 7.80% | 8.57% | 1.59% | 0.59% | -4.47% | 0.15% | -3.45% | -1.21% | 4.51% | 1.39% | 11.19% | 32.98% |
| 2014 | -0.14% | 0.14% | -4.27% | 3.29% | 0.72% | 4.10% | -4.08% | 4.47% | 4.55% | 0.00% | 6.55% | 5.09% | 21.63% |
| 2013 | 3.16% | 12.89% | 7.63% | -4.20% | -4.74% | 0.88% | -1.01% | -0.00% | 5.12% | -3.90% | 0.16% | 3.08% | 19.13% |
Risk-Adjusted Performance
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Dechra Pharmaceuticals plc (DPH.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Dechra Pharmaceuticals plc granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to £0.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | £0.00 | £0.13 | £0.45 | £0.41 | £0.34 | £0.32 | £0.26 | £0.21 | £0.18 | £0.17 | £0.15 | £0.14 |
Dividend yield | 0.00% | 0.32% | 1.71% | 0.76% | 0.99% | 1.09% | 1.23% | 1.02% | 1.37% | 1.55% | 1.84% | 1.99% |
Monthly Dividends
The table displays the monthly dividend distributions for Dechra Pharmaceuticals plc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | £0.00 | £0.00 | |||||||||||
| 2023 | £0.00 | £0.00 | £0.13 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.13 |
| 2022 | £0.00 | £0.00 | £0.12 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.33 | £0.00 | £0.00 | £0.45 |
| 2021 | £0.00 | £0.00 | £0.11 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.29 | £0.00 | £0.00 | £0.41 |
| 2020 | £0.00 | £0.00 | £0.10 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.24 | £0.00 | £0.34 |
| 2019 | £0.00 | £0.00 | £0.10 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.22 | £0.00 | £0.00 | £0.32 |
| 2018 | £0.00 | £0.00 | £0.07 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.18 | £0.00 | £0.00 | £0.26 |
| 2017 | £0.00 | £0.00 | £0.06 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.15 | £0.00 | £0.00 | £0.21 |
| 2016 | £0.00 | £0.00 | £0.06 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.13 | £0.00 | £0.00 | £0.18 |
| 2015 | £0.00 | £0.00 | £0.05 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.12 | £0.00 | £0.00 | £0.17 |
| 2014 | £0.00 | £0.00 | £0.05 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.11 | £0.00 | £0.15 |
| 2013 | £0.04 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.00 | £0.10 | £0.00 | £0.14 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Dechra Pharmaceuticals plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Dechra Pharmaceuticals plc was 78.05%, occurring on Mar 4, 2003. Recovery took 507 trading sessions.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -78.05% | Feb 28, 2001 | 469 | Mar 4, 2003 | 507 | Mar 10, 2005 | 976 |
| -52.97% | Aug 24, 2021 | 283 | Oct 7, 2022 | — | — | — |
| -35.9% | Aug 14, 2018 | 70 | Nov 20, 2018 | 432 | Aug 6, 2020 | 502 |
| -30.88% | Jun 2, 2008 | 133 | Dec 4, 2008 | 226 | Oct 28, 2009 | 359 |
| -25.2% | Feb 2, 2010 | 102 | Jun 29, 2010 | 82 | Oct 22, 2010 | 184 |
Volatility
Volatility Chart
The current Dechra Pharmaceuticals plc volatility is 0.45%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Dechra Pharmaceuticals plc.
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |